Ondine Biomedical Inc. (LON:OBI – Get Free Report) shares traded down 11% on Tuesday . The stock traded as low as GBX 5.78 ($0.08) and last traded at GBX 5.88 ($0.08). 83,300 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 263,937 shares. The stock had previously closed at GBX 6.60 ($0.09).
Ondine Biomedical Stock Performance
The company’s 50 day moving average price is GBX 7.48 and its two-hundred day moving average price is GBX 7.68. The firm has a market cap of £15.60 million, a PE ratio of -137.50 and a beta of 0.10. The company has a quick ratio of 8.26, a current ratio of 1.36 and a debt-to-equity ratio of 25.95.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Stories
- Five stocks we like better than Ondine Biomedical
- What does consumer price index measure?
- How Much Can You Make in Stocks in One Month?
- What is a Low P/E Ratio and What Does it Tell Investors?
- This Is the Top Large-Cap Stock Insiders Are Buying
- The Risks of Owning Bonds
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
